Skip to content

Journey Medical Corporation DERM Business Segments — Legal Fees

Similar metrics at other companies

Ashland logo
ASHLegal Fees
$1M
OS Therapies logo
OSTXLegal Fees
$308.81K
Lincoln National logo
LNCLegal Fees
$122M
American Coastal Insurance Corporation logo
ACICLegal Fees
$94K-60.0%
Virtu Financial logo
VIRTLegal Fees
$0-100%
Tetra Tech logo
TTEKLegal Fees
$0

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+21.1%
Enterprise value$193.19M+16.4%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:LegalFees.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's business segments — legal fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's business segments — legal fees?
Journey Medical Corporation (DERM) reported business segments — legal fees of $601K in Q1 2026.
How has Journey Medical Corporation's business segments — legal fees changed year-over-year?
Journey Medical Corporation's business segments — legal fees increased by 17.2% year-over-year, from $513K to $601K.
What does business segments — legal fees mean?
Covers external legal costs, including intellectual property protection, regulatory litigation, and general corporate legal support for the dermatological segment. High levels may indicate ongoing regulatory challenges or efforts to defend product patents.